Arthrocentesis with iPRF, PRP + hyaluronic acid, or saline in arthrogenic TMD: 12-month outcomes from a retrospective cohort study
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
INTRODUCTION: Arthrocentesis improves pain and function in arthrogenic temporomandibular disorders (TMD), but the added value of biologics such as injectable platelet-rich fibrin (iPRF), platelet-rich plasma (PRP), and hyaluronic acid (HA) is uncertain. MATERIALS AND METHODS: This retrospective cohort study included 44 patients (33 females, 11 males) with arthrogenic TMD who underwent arthrocentesis between 2022 and 2024. Patients received iPRF (n = 18), PRP-HA (n = 12), or saline (NaCl; n = 14). The primary endpoint was pain at rest (VAS 0-10). Secondary outcomes included pain on mastication (VAS) and palpation (temporomandibular joint (TMJ), temporalis, masseter and lateral pterygoid muscle; binary), maximum interincisal distance (MID), and TMJ noises. Follow-up was performed at 1 week, 1, 3, 6, and 12 months after surgery. RESULTS: All groups showed significant postoperative improvements in pain at rest and during mastication, with no differences between groups for the primary endpoint. In secondary outcomes, PRP-HA was associated with the lowest prevalence of TMJ noises in the first week (8.3%), first and 12 month (8.3% and 10%, respectively; p < 0.0001) and with the most consistent MID values over follow-up. It also showed the most sustained absence of temporalis muscle pain at the whole 12 months period (p < 0.0001). By contrast, iPRF was linked to transiently higher muscle tenderness; saline showed greater variability including late lateral pterygoid pain. CONCLUSION: Arthrocentesis provides durable pain relief in arthrogenic TMD independent of the adjunctive injectate. While no differences were observed for the primary endpoint, secondary outcomes indicate that PRP-HA may be associated with favorable effects on joint noises and muscle tenderness, warranting further investigation.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Arthrocentesis with iPRF, PRP + hyaluronic acid, or saline in arthrogenic TMD: 12-month outcomes from a retrospective cohort study
- Date Crossref
- 01/09/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.